A Stewart K, Dimopoulos MA, Masszi T, Spicka I, Oriol A, Hajek R, RosiƱol L, Siegel DS, Niesvizky R, Jakubowiak AJ et al..
2016.
Health-Related Quality-of-Life Results From the Open-Label, Randomized, Phase III ASPIRE Trial Evaluating Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple Myeloma.. J Clin Oncol. 34(32):3921-3930.